ISTANBUL - Sinovac Biotech has licensed its COVID-19 vaccine for production in five countries - Turkey, Indonesia, Brazil, Malaysia and Egypt, CEO Yin Weidong told Bloomberg News in an interview.

In the interview on Tuesday Weidong said the company supplied 260 million doses of its COVID-19 vaccine globally last month, with over 60% of those going to countries outside China.

In Turkey, the Sinovac vaccine is being used as well as the Pfizer/BioNTech vaccine . It has also signed a deal for 50 million doses of Russia's Sputnik V COVID-19 vaccine.

 

(Reporting by Daren Butler; Editing by Jonathan Spicer) ((daren.butler@tr.com; +90-212-350 7053; Reuters Messaging: daren.butler.thomsonreuters.com@reuters.net))